Activation molecules (CD38 and HLA‐DR) and inhibitory molecule PD‐1 expressions on T cells were significantly higher but percentages of CD28+CD8+T cells were lower in active SLE patients compared with those in the other two groups. This evidence concerns the gene CD38 and systemic lupus erythematosus.